Teleflex Receives Historic FDA Approval for EZPLAZ™ Freeze Dried Plasma, Expanding Emergency Blood Transfusion Options Teleflex Incorporated, a global leader in medical technology and innovative healthcare solutions, has announced a…
VDyne Launches Pivotal TRIVITA Study, Treats First Patient with TriNova™ Transcatheter Tricuspid Valve Replacement System VDyne Inc., a privately held medical device company focused on advancing structural heart therapies, has…
PK MED Strengthens Leadership and Scientific Governance to Advance ARTHRELIS and ENGRAFTIS Development Programs PK MED, a French biotechnology company established by healthcare investment firm Truffle Capital, has announced a…
Virta Health Study Suggests Nutrition-Based Metabolic Care May Significantly Reduce Risk of Chronic Kidney Disease Virta Health, a leader in reversing metabolic disease through individualized nutrition-based care, has announced the…
Aqtual Strengthens Executive Leadership with Appointment of Daniil Kalyuzhny as Chief Financial Officer to Support Next Phase of Growth Aqtual, Inc., a precision medicine company pioneering active chromatin cell-free DNA…
Niagen Bioscience Publishes New Research Linking Niagen® Supplementation to Reduced Biological Aging in Skeletal Muscle Niagen Bioscience, Inc., a global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy aging…
Vergent Bioscience Reports Promising Phase 2B Results for Abenacianine, Advancing Real-Time Tumor Imaging During Lung Cancer Surgery Vergent Bioscience, a clinical-stage biotechnology company focused on developing innovative tumor-targeted imaging technologies,…
Mainstay Medical Achieves Coverage Milestone with Highmark Mainstay Medical Holdings plc has announced a significant reimbursement milestone for its ReActiv8 Restorative Neurostimulation™ therapy, following a favorable coverage decision from Highmark…
Shionogi Launches XOCOVA® in the United States as the First Oral Post-Exposure COVID-19 Prevention Therapy Shionogi Inc., the U.S. subsidiary of Japan-based pharmaceutical company Shionogi & Co., Ltd., has announced…
Secretome Therapeutics Strengthens Executive Leadership Team to Advance Rare Disease Pipeline and Regenerative Medicine Platform Secretome Therapeutics, a clinical-stage biotechnology company developing regenerative therapies derived from neonatal cardiac progenitor cells…
Feinstein Institutes Reveals the World’s First Comprehensive Vagus Nerve Map Northwell Health’s Feinstein Institutes for Medical Research has announced the release of the world’s first comprehensive anatomical map of the…
Sarepta Therapeutics Appoints Michael Severino as Chief Executive Officer to Lead Next Phase of Precision Genetic Medicine Growth Sarepta Therapeutics, Inc., a global biotechnology company recognized for its leadership in…